Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Unusual side effects of interferon Beta-1a in patient with multiple sclerosis.
[Low back pain: atypical presentation of multiple sclerosis.]
Alterations of brain eicosanoid synthetic pathway in multiple sclerosis and in animal models of demyelination: Role of cyclooxygenase-2.
Beneficial effects of galantamine on performance in the object recognition task in Swiss mice: deficits induced by scopolamine and by prolonging the retention interval.
A preliminary path analysis: Effect of psychopathological symptoms, mental and physical dysfunctions related to quality of life and body mass index on fatigue severity of Iranian patients with multiple sclerosis.
[The impact of the vitamin D in neurological diseases and neurorehabilitation: from demencia to multiple sclerosis. Part I: the role of the vitamin D in the prevetion and treatment of multiple sclerosis].
Width of 3. Ventricle: reference values and clinical relevance in a cohort of patients with relapsing remitting multiple sclerosis.
Actively Induced Experimental Autoimmune Encephalomyelitis in Rats.
Aquaporin-4: A novel diagnostic biomarker for seronegative neuromyelitis optica.
Vitamin D Actions on CD4(+) T Cells in Autoimmune Disease.
Impact of Helicobacter pylori on multiple sclerosis-related clinically isolated syndrome.
Combination therapy with lenalidomide and nanoceria ameliorates CNS autoimmunity.
Deficits in tongue motor control are linked to microstructural brain damage in multiple sclerosis: a pilot study.
Exome and regulatory element sequencing of neuromyelitis optica patients.
Transcriptional activity of endogenous retroviruses in multiple sclerosis: a sign of deficient chromatin-mediated silencing.
Objectification of psychogenic postural instability by trunk sway analysis.
Parasite Infections in Multiple Sclerosis Modulate Immune Responses through a Retinoic Acid-Dependent Pathway.
Validation of the Neurological Fatigue Index for Stroke (NFI-Stroke).
Th17 Pathway As a Target for Multipotent Stromal Cell Therapy in Dogs: Implications for Translational Research.
Quantifying Demyelination in NK venom treated nerve using its electric circuit model.
Internet-based home training is capable to improve balance in multiple sclerosis: a comparative trial with hippotherapy.
Reduction in parvalbumin-positive interneurons and inhibitory input in the cortex of mice with experimental autoimmune encephalomyelitis.
Beta2-microglobulin as a diagnostic marker in cerebrospinal fluid: a follow-up study.
Multiple sclerosis.
Regulation of Th1 cells and experimental autoimmune encephalomyelitis by glycogen synthase kinase-3.
Pages
« first
‹ previous
…
652
653
654
655
656
657
658
659
660
…
next ›
last »